11:30 EDT Protagonist Therapeutics (PTGX) resumes, up 28% after report of J&J takeover talks
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTGX:
- Protagonist Therapeutics trading resumes
- J&J in talks to buy Protagonist Therapeutics, WSJ reports
- Protagonist Therapeutics jumps 9%, halted after WSJ report on J&J takeover talks
- Johnson & Johnson in talks to buy Protagonist Therapeutics, WSJ reports
- Protagonist Therapeutics trading halted, volatility trading pause